Erratum: Prognosis in the era of comparative effectiveness research: Where is nuclear cardiology now and where should it be? (Journal of Nuclear Cardiology DOI: 10.1007/S12350-012-9593-Y)

Journal of Nuclear Cardiology

Volumn 19, Issue 5, 2012, Pages 1092-1093

  Shaw, Leslee J ^a   Hage, Fadi G ^b,c   Berman, Daniel S ^d   Hachamovitch, Rory ^e   Iskandrian, Ami ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c BIRMINGHAM VA MEDICAL CENTER   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERRATUM; ERROR; PRIORITY JOURNAL; ARTICLE; CARDIOLOGY; COMPARATIVE EFFECTIVENESS; DIAGNOSIS; DRUG THERAPY; EVENT FREE SURVIVAL; HUMAN; OVERALL SURVIVAL; PROGNOSIS;

EID: 84868192888     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-012-9605-y     Document Type: Erratum

References (2)

1. Herzog BA, Husmann L, Valenta I, Gaemperli O, Siegrist PT, Tay FM, Burkhard N, Wyss CA, Kaufmann PA. Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol. 2009;54(2):150-6.
2. Murthy VL, Naya M, Foster CR, Hainer J, Gaber M, Di Carli G, Blankstein R, Dorbala S, Sitek A, Pencina MJ, Di Carli MF. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation. 2011;124(20):2215-24.